Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecruitment has been closed, as indicated by the new 'No longer looking for participants' note on the study page. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the page footer shows Revision: v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedA new revision label v3.5.5 was added and the previous v3.5.4 was removed, signaling a small release update to the page.SummaryDifference0.1%

- Check36 days agoChange DetectedUpdated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the study page content and its tracking version.SummaryDifference0.1%

- Check51 days agoChange DetectedThe revision indicator changed from v3.5.2 to v3.5.3. This reflects a new build/update of the site and does not modify the study details displayed on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No changes to the study details or navigation are evident.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.